Modulation of behavioral networks by selective interneuronal inactivation

Area of Science:

• Neuroscience
• Molecular Psychiatry
• Genetics

Background:

• Gamma-aminobutyric acid (GABA)-ergic system dysfunction is central to schizophrenia and other neuropsychiatric disorders.
• This dysfunction involves multiple interneuronal cell types, highlighting the need for cell-type-specific investigation.

Purpose of the Study:

• To investigate the cell-type-specific roles of glutamic acid decarboxylase 1 (GAD1) in interneurons within the context of neuropsychiatric disorders.
• To elucidate how suppressing GAD1 in distinct interneuron populations (cholecystokinin-positive [CCK+] and neuropeptide Y-positive [NPY+]) affects molecular profiles and behavior.

Main Methods:

• Generation of transgenic mouse lines using bacterial artificial chromosome-driven miRNA silencing to specifically suppress GAD1 in CCK+ or NPY+ interneurons.
• In situ lipidomic and proteomic analyses of brain tissue sections to identify molecular changes.
• Comprehensive behavioral analyses, including locomotor activity, sensory function, anxiety-related behaviors, social interaction, and amphetamine sensitivity.

Main Results:

• Distinct, brain region-specific molecular profiles were observed in each transgenic line.
• Suppression of GAD1 in CCK+ interneurons led to locomotor and olfactory sensory deficits.
• Suppression of GAD1 in NPY+ interneurons resulted in altered anxiety-related behaviors and social interaction.
• Both lines exhibited modified amphetamine sensitivity, with opposing effects observed between the two groups.

Conclusions:

• Reduced GAD1 expression impacts molecular and behavioral phenotypes in a cell type-dependent manner.
• Specific interneuron subpopulations (CCK+ and NPY+) act as critical, opposing modulators of dopamine system function.
• These findings support the hypothesis that diverse inhibitory subnetworks differentially control neuronal network activity.